Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cell Reports|June 4, 2013
Tumor suppression by p53: is apoptosis important or not?Hestia Mellert, Joaquín M Espinosa
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Development of a TCR beta repertoire assay for profiling liquid biopsies from NSCLC donorsLeisa P Jackson, Benjamin A Tjoa, Hestia Mellert, et al.
Cell Cycle (Georgetown, Tex.)|May 31, 2007
The ARF/oncogene pathway activates p53 acetylation within the DNA binding domainHestia Mellert, Stephen M Sykes, Maureen E Murphy, et al.
Diagnostics (Basel, Switzerland)|December 5, 2020
Design and Characterization of a Novel Blood Collection and Transportation Device for Proteomic ApplicationsNathan K Kaiser, Maximillian Steers, Charles M Nichols, et al.
Diagnostics (Basel, Switzerland)|January 26, 2021
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLCHestia Mellert, Jordan Reese, Leisa Jackson, et al.
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Longitudinal monitoring for the emergence of epidermal growth factor C797S resistance mutations in non-small cell lung cancer using blood-based droplet digital PCRMark Bowling, Hyder Arastu, Victoria Edwards, et al.
Diagnostics (Basel, Switzerland)|March 25, 2022
Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping VariantsAudrey Audetat, Chérie Tschida, Sarah Kreston, et al.
Molecular Oncology|June 26, 2016
A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 inductionJessica A Monteith, Hestia Mellert, Morgan A Sammons, et al.
Cancer Cell|October 19, 2010
Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferasePriya Aggarwal, Laura Pontano Vaites, Jong Kyong Kim, et al.
The Journal of Molecular Diagnostics : JMD|April 24, 2017
Development and Clinical Utility of a Blood-Based Test Service for the Rapid Identification of Actionable Mutations in Non-Small Cell Lung CarcinomaHestia Mellert, Trudi Foreman, Leisa Jackson, et al.
Pageof 2